Release date: 5 March 2021
Promoter – Financial IntermediaryCOMUNIDAD AUTONOMA DE MADRID
Financing of eligible investments incurred by the regional government of Madrid in relation to the COVID-19 pandemic.
Additionality and Impact
The project will contribute to the region's Covid-19
response efforts including the prevention of new infections and timely deployment
of the Covid-19 immunisation program. It will bring healthcare benefits in the
form of higher immunity and lower mortality, thereby presenting significant
positive externalities as improved confidence leads to the reopening of the
local economy. The EIB loan, which
offers an optional irregular repayment profile, will effectively contribute to
project implementation by facilitating relatively long-term financing at
favourable market rates. This operation is part of the EIB Group response to
The project will contribute to the region's preparedness, response and vaccination efforts in the fight against COVID-19.
- Health - Human health and social work activities
Proposed EIB finance (Approximate amount)
EUR 200 million
Total cost (Approximate amount)
EUR 200 million
The project concerns operational and capital expenditures that are expected to be carried out in the Promoter's existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2014/52/EU amending the EIA Directive 2011/92/EU. However, in case the Promoter is notified by one of the competent environmental authorities that one of the components constituting the project should require an EIA or equivalent, a copy of such EIA needs to be sent to the EIB once established.
The Promoter has to ensure that contracts for the implementation of the project have been and will be tendered in accordance with the relevant applicable EU procurement legislation: Directive 2014/24/EU, as well as Directive 89/665/EEC as interpreted by the Court of Justice of the EU, with publication of tender notices in the Official Journal of the EU, as and where required.
Signed - 30/04/2021
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).